<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Goldenberg, Ilan</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Wearable Defibrillator is a Safe Bridge to ICD Therapy Decision-Making</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-12</style></pages><abstract><style  face="normal" font="default" size="100%">A registry and a follow-up of patients using the LifeVest Wearable Cardiac Defibrillator (WCD), WEARIT-II, shows that the vest saves lives and can be safely used to bridge a decision for appropriate implantable cardioverter defibrillator therapy. The purpose of the study was to provide prospective data on the safety and efficacy of a bridging strategy with the WCD in a real-world setting. This article presents 18-month results for the first 882 patients enrolled in the United States from August 2011 through April 2013.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>